INDEPENDENT PERSPECTIVE. A WIDER WORLD.
TUESDAY
NOVEMBER 17, 2026

YOUR WORLD, IN FOCUS

The Daily Brief.

Politics. Science. And the wider world.

MIDDAY EDITION · 11:54 A.M. ET
15 STORIES · 5 SECTIONS
THE NOVEMBER 17 EDITION

THE BIG PICTURE / U.S. POLITICS

White House testimony directive sets up an oversight dispute.

Agencies face a new sign-off requirement before testifying to Congress. The latest edition also tracks Middle East tensions, trade concessions, AI infrastructure and medical research.

United States Capitol west front, 1997 archival photograph; not the current event.United States Capitol · 1997
THE MARKET CLOSENov 16 · Final regular-session close
S&P 5007,416.59 −1.92% ↘
NASDAQ24,509.76 −2.49% ↘
DOW JONES51,608.17 −1.41% ↘
AP source ↗

MAKE SENSE OF THE DAY

Inside the edition

Washington coverage examines agency testimony clearance, research-grant cancellations and aviation infrastructure. World stories distinguish conflicting accounts of the Bahrain drone incident, uncertainty over Kerch Bridge damage and China–Canada trade talks.

Markets covers Monday’s completed selloff, Nvidia’s leadership transition and the Fed’s productivity scenarios. Science examines modeled electricity demand, remote-computing controls and single-cell gene-editing measurements. Health covers a breast-cancer approval and randomized evidence on mobility and adolescent tirzepatide.

ON THE HORIZON · NOVEMBER 17 EDITION

What to watch

17 NOV

Nvidia earnings update

The scheduled update will test expectations for AI demand; outcomes were unreported at the Brief’s 11:54 a.m. cutoff.

18 NOV

Federal Reserve minutes

The scheduled October FOMC meeting minutes will provide more detail on the policy discussion.

ONGOING

FDA follow-up

Follow FDA updates on postapproval safety and companion diagnostics.

EDITION PROGRESS0 / 15 stories